San Francisco, CA - Hormonal Contraceptive Market is expected to reach USD 26.2 billion by 2025. The hormonal contraceptive is termed as a birth control method, which acts on an endocrine system. The method is mainly used to prevent ovulation using female hormones. Progesterone and/or estrogen, or combination of these hormones are the two main forms of hormonal contraception.
These hormones may be implanted into body tissue, absorbed from a patch on the skin, may be taken orally, injected under the skin, or placed in the vagina. The Hormonal Contraceptive Market is estimated to grow at a significant CAGR of 4.0% over the future period as the scope and its applications are rising enormously across the globe.
Request a PDF Sample @ https://www.millioninsights.com/industry-reports/hormonal-contraceptive-market/request-sample
High demand for hormonal contraception for birth control, growing female population, urbanization and raised awareness regarding hormonal contraception, and availability of low cost contraceptive practices are documented as major factors of Hormonal Contraceptive Market that are estimated to enhance the growth in the years to come. However, adverse side effects and key barrier for global market are the factors that may restrain overall market growth in the coming years. Hormonal Contraceptive Market is segmented based on product type, methods, end use, and region.
Implantation, oral pill, injection, skin patch, intrauterine device (IUD), and other products could be explored in Hormonal Contraceptive Market in the forecast period. Oral pill is also termed as “the pill” that contains grouping of female hormones, progesterone and estrogen. The pill helps to prevent the risk of pregnancy by keeping the lining of the uterus thin and by avoiding ovulation. Intrauterine device (IUD) is a T-shapes small device, which is implanted into uterus that help to prevent pregnancy. The effect of device is for many years and can be removed at certain period. Hormonal IUD and Copper IUD are the two main intrauterine devices.
Globally, North America accounted for the largest market share of Hormonal Contraceptive in terms of revenue and is estimated to continue its dominance in the coming years. The reason behind growth of overall market could be presence of key manufacturers in the region and comfort of use. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The developing countries like India and China are the major consumers of this market in the region.
Regional Analysis For Hormonal Contraceptive Market:
For comprehensive understanding of market dynamics, the global Hormonal Contraceptive Market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Significant Features that are under Offering and Key Highlights of the Reports:
- Detailed overview of Hormonal Contraceptive Market
- Changing market dynamics of the industry
- In-depth market segmentation by Type, Application etc
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape of High-Performance Alloys Market
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth.
For More Technical Insights, Download Brochure @ https://www.millioninsights.com/industry-reports/hormonal-contraceptive-market
Advancements in the field of medical tools, medical technology along with the integration of data analytics, and 3D printing in this industry are enhancing the role in sustaining quality facilities at hospitals, clinics, and homes.
It is considered to be crucial for the services offered for the prevention, diagnosis, and treatment of diseases and illnesses.
This industry comprises of an enormous number of products ranging from surgical gloves to artificial joints to imaging equipment which plays a crucial role in the development of medical technologies.Advancements in technology and its adoption are improving the complexity and accuracy of disease screening with the approval of smart devices applicable for remote monitoring of patients.
Expert consultation with medical device manufacturers reveals that they are hesitant due to the perceived barriers to obtain ethical approval.
This industry is undergoing significant advances in terms of minimally invasive surgery, orthopaedic surgeries, cardiology, neurology, oncology, and medical imaging.This market is moderately fragmented and is in the growth phase is trying to gain a higher market share.
Hospitality and surgical centres are foreseen to dominate this market with the highest demand for this segment in 2018.
The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate.
We salute the industry experts helping companies survive and sustain in this pandemic.At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Embolotherapy Market.
We are working diligently to help companies take rapid decisions by studying:The impact of COVID-19 on the Embolotherapy Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the marketThe rapid shifts in the strategies of the Top 50 companies in the Embolotherapy MarketThe shifting short-term priorities of the top 50 companies’ clients and their client’s clientsYou can request an in-depth analysis detailing the impact of COVID-19 on the Embolotherapy Market:Let’s fight this crisis together.
@ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=185897830According to the new market research report “Embolotherapy Market by Product (Embolic Agents (Microspheres, Detachable Coils, Pushable Coils), Guidewires), Disease (Oncology, Aneurysm, Peripheral Vascular), Procedure, End User (Hospitals, Clinics, ASC, Academia) – Global Forecast to 2024“, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).Embolotherapy Market is projected to reach USD 4.9 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 8.1% from 2019 to 2024.The growth of the Embolotherapy Market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario.The embolic agents segment accounted for the largest share of the Embolotherapy Market, by product, in 2019Based on product, the Embolotherapy Market is segmented into embolic agents (embolic coils, embolic plug systems, liquid embolic agents, microspheres, and detachable balloons) and support devices (microcatheters and guidewires).
Microspheres accounted for the largest share of the Embolotherapy Market in 2018.
Market growth in this segment is attributed to the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies.Browse in-depth TOC on “Embolotherapy Market”184 – Tables37 – Figures219 – PagesRequest Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=185897830The cancer segment is projected to hold the largest share of the market by disease indication during the forecast period of 2019 to 2024By disease indication, the Embolotherapy Market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders.
